Fevertree Drinks PLC reported earnings per share of $0.15, surpassing analyst expectations, supported by an adjusted EBITDA of £20.10 million. While its revenue of $218.87 million fell short of estimates, the company saw significant growth in key markets: US revenue rose 11%, UK by 3%, and Europe by 10%. The company's strong financial health is reflected in its low debt-to-equity ratio and solid liquidity, positioning it well for continued expansion in the premium drink mixer market.
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Arbitrum (ARB) token surged 4.73% within one hour on October 20, reaching $0.1972 on Binance, driven by significant short-position liquidations across Binance, Bybit, and OKX. About $70,000 in short positions were liquidated, far exceeding the $10,00...
